Showing results (1-10 of 535) with videos related to
Sort By:
Pageof 54
Oncology Research and Treatment|February 19, 2016
State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic LeukemiaPaula Cramer, Michael Hallek, Barbara EichhorstSeminars in Oncology|April 5, 2016
Initial therapy of chronic lymphocytic leukemiaBarbara Eichhorst, Paula Cramer, Michael HallekEuropean Journal of Haematology|September 3, 2015
Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG)Paula Cramer, Petra Langerbeins, Barbara Eichhorst, et al.Deutsche Medizinische Wochenschrift (1946)|August 14, 2020
[Current diagnosis and treatment of chronic lymphocytic leukaemia]Paula Cramer, Julia von Tresckow, Barbara Eichhorst, et al.Best Practice & Research. Clinical Haematology|October 16, 2016
Current strategies to create tailored and risk-adapted therapies for CLL patientsPaula Cramer, Barbara Eichhorst, Hans Christian Reinhardt, et al.Best Practice & Research. Clinical Haematology|August 21, 2007
Revision of the guidelines for diagnosis and therapy of chronic lymphocytic leukemia (CLL)Barbara Eichhorst, Michael HallekHematology. American Society of Hematology. Education Program|December 4, 2016
Prognostication of chronic lymphocytic leukemia in the era of new agentsBarbara Eichhorst, Michael HallekLeukemia & Lymphoma|April 29, 2014
Emerging therapies for refractory chronic lymphocytic leukemiaNadine Kutsch, Michael Hallek, Barbara EichhorstHematology. American Society of Hematology. Education Program|December 7, 2019
Relapsed disease and aspects of undetectable MRD and treatment discontinuationBarbara Eichhorst, Moritz Fürstenau, Michael HallekLeukemia & Lymphoma|February 7, 2009
Treatment of elderly patients with chronic lymphocytic leukemiaBarbara Eichhorst, Valentin Goede, Michael HallekPageof 54